300888 稳健医疗
2026/03 - 三个月
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入2,679,3292.84%10,949,4908,977,8548,185,02211,351,332
减:营业总成本2,345,2983.95%9,733,8087,996,3057,285,3449,119,688
    其中:营业成本1,368,5391.91%5,733,4634,729,5624,174,5975,972,801
               财务费用34,92421,542.54%6,653(99,211)(61,859)(122,575)
               资产减值损失(18,646)-43.91%(251,273)(242,896)(393,762)(362,869)
公允价值变动收益12,133457.13%(24,340)2,86246,67832,149
投资收益972-78.82%53,09275,388127,34351,471
    其中:对联营企业和合营企业的投资收益(5,702)-10.81%(27,220)(11,306)1,5824,698
营业利润352,6333.60%1,067,678914,863817,9701,976,550
利润总额348,1684.15%1,047,821908,348749,8461,919,506
减:所得税费用77,4106.72%233,703167,642121,301245,169
净利润270,7583.44%814,118740,706628,5451,674,337
减:非控股权益19,26746.17%46,15045,32748,14223,620
股东净利润251,4901.18%767,967695,379580,4031,650,717

市场价值指针
每股收益 (元) *0.4300.00%1.3201.1900.9802.790
每股派息 (元) *----0.7500.6500.5001.900
每股净资产 (元) *20.1762.96%19.777--19.40427.444
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容